Quadrant Capital Group LLC Buys 329 Shares of Corteva, Inc. (NYSE:CTVA)

Quadrant Capital Group LLC boosted its position in shares of Corteva, Inc. (NYSE:CTVA) by 4.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,001 shares of the company’s stock after acquiring an additional 329 shares during the period. Quadrant Capital Group LLC’s holdings in Corteva were worth $399,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in CTVA. Ilmarinen Mutual Pension Insurance Co lifted its stake in shares of Corteva by 44.4% during the 4th quarter. Ilmarinen Mutual Pension Insurance Co now owns 65,000 shares of the company’s stock valued at $3,702,000 after buying an additional 20,000 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Corteva by 36.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 2,215,926 shares of the company’s stock valued at $126,219,000 after acquiring an additional 597,739 shares in the last quarter. Aviva PLC boosted its stake in shares of Corteva by 1,424.4% in the fourth quarter. Aviva PLC now owns 411,385 shares of the company’s stock worth $23,432,000 after acquiring an additional 384,398 shares during the period. Resona Asset Management Co. Ltd. purchased a new stake in shares of Corteva during the fourth quarter worth about $11,582,000. Finally, World Investment Advisors raised its stake in Corteva by 46.5% during the 4th quarter. World Investment Advisors now owns 7,941 shares of the company’s stock valued at $452,000 after purchasing an additional 2,520 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Trading Down 0.5 %

CTVA stock opened at $55.54 on Tuesday. The firm’s fifty day simple moving average is $62.18 and its two-hundred day simple moving average is $60.28. The stock has a market capitalization of $37.93 billion, a price-to-earnings ratio of 43.05, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.22%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva’s payout ratio is currently 52.71%.

Analyst Ratings Changes

CTVA has been the subject of a number of research analyst reports. UBS Group cut their price objective on shares of Corteva from $74.00 to $73.00 and set a “buy” rating for the company in a report on Friday, January 10th. Oppenheimer lifted their price target on shares of Corteva from $70.00 to $72.00 and gave the company an “outperform” rating in a report on Friday, February 7th. Citigroup increased their price objective on shares of Corteva from $69.00 to $74.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Royal Bank of Canada lifted their target price on Corteva from $72.00 to $73.00 and gave the stock an “outperform” rating in a report on Friday, February 7th. Finally, KeyCorp raised their price target on Corteva from $68.00 to $70.00 and gave the company an “overweight” rating in a report on Friday, February 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, Corteva currently has an average rating of “Moderate Buy” and an average target price of $68.06.

Insider Buying and Selling at Corteva

In other Corteva news, insider Brian Titus sold 26,560 shares of the business’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now directly owns 11,347 shares of the company’s stock, valued at $723,257.78. The trade was a 70.07 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.14% of the stock is currently owned by corporate insiders.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.